Patients who were not given aspirin before artery-clearing coronary angioplasty were found to have a significantly higher in-hospital death rate, shows research. Aspirin use before angioplasty is a Class I recommendation of the American College of Cardiology and American Heart Association, the highest level of evidence for ACC/AHA guidelines. Aspirin has well-documented anti-platelet activity in reducing the risk of cardiac events. Researchers ...
View the Original article
